Showing results (261-270 of 347) with videos related to
Sort By:
Pageof 35
The Journal of Urology|May 25, 2021
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical CystectomyAlberto Martini, Luca Afferi, Stefania Zamboni, et al.World Journal of Urology|March 2, 2017
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomyMarco Moschini, Beat Foerster, Mohammad Abufaraj, et al.Journal of Surgical Oncology|May 1, 2023
Age represents the main driver of surgical decision making in patients candidate to radical cystectomyPaolo Dell'Oglio, Stefano Tappero, Andrea Panunzio, et al.World Journal of Urology|September 25, 2024
Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complicationsMarco Oderda, Romain Diamand, Rawad Abou Zahr, et al.Cell Death & Disease|March 1, 2019
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseasesLudovica Grassi, Romina Alfonsi, Federica Francescangeli, et al.Cell Death & Disease|June 22, 2021
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancerMichele Signore, Romina Alfonsi, Giulia Federici, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2025
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 StudySiamak Daneshmand, Michiel S Van der Heijden, Joseph M Jacob, et al.Oncotarget|January 7, 2017
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinomaFederico Pio Fabrizio, Manuela Costantini, Massimiliano Copetti, et al.Urologic Oncology|January 16, 2025
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancerSiamak Daneshmand, Ashish M Kamat, Neal D Shore, et al.BJU International|September 22, 2022
Oncological and safety profiles in patients undergoing simultaneous transurethral resection (TUR) of bladder tumour and TUR of the prostateEkaterina Laukhtina, Marco Moschini, Wojciech Krajewski, et al.Pageof 35